STOCK TITAN

HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 34th ANNUAL HEALTHCARE CONFERENCE

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will engage in a fireside chat and individual investor meetings at the Piper Sandler 34th Annual Healthcare Conference on November 30, 2022, at 9:00 am ET in New York, NY. A webcast of this chat will be accessible on Harmony's investor webpage. The company, based in Plymouth Meeting, PA, focuses on innovative therapies for rare neurological diseases, emphasizing patient-centric solutions since its establishment in 2017.

Positive
  • None.
Negative
  • None.

PLYMOUTH MEETING, Pa., Nov. 9, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's management will participate in a fireside chat and host investor meetings at the upcoming Piper Sandler 34th Annual Healthcare Conference.

●    Piper Sandler 34th Annual Healthcare Conference
          Location: New York, NY
          Fireside Chat: Wednesday, November 30, 2022, at 9:00 am ET
          1x1 Meetings: Wednesday, November 30, 2022

A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.  

About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Cate McCanless
202-420-7888
cmccanless@harmonybiosciences.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-piper-sandler-34th-annual-healthcare-conference-301672289.html

SOURCE Harmony Biosciences

FAQ

What is the date and time of Harmony Biosciences' fireside chat at the Piper Sandler conference?

The fireside chat will take place on November 30, 2022, at 9:00 am ET.

Where is the Piper Sandler 34th Annual Healthcare Conference being held?

The conference will be held in New York, NY.

How can I watch the webcast of the fireside chat for Harmony Biosciences?

The webcast will be available on Harmony's investor page at their official website.

What does Harmony Biosciences focus on?

Harmony Biosciences focuses on developing therapies for rare neurological diseases.

When was Harmony Biosciences founded?

Harmony Biosciences was established in 2017.

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

1.91B
38.55M
11.62%
92.83%
10.62%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PLYMOUTH MEETING